Karnofsky Performance Scale Calculator
Assess patient functional status using the Karnofsky Performance Status scale (0-100). Enter values for instant results with step-by-step formulas.
Calculator
Adjust values & calculateAble to carry on normal activity and work
Good - candidate for aggressive therapy
Formula
The Karnofsky Performance Status scale rates patient functional capacity from 0 (dead) to 100 (normal function, no complaints). Scores are assigned in increments of 10 based on the patient ability to perform normal activities, self-care requirements, and need for institutional or medical assistance.
Last reviewed: January 2026
Worked Examples
Example 1: Post-Surgical Brain Tumor Patient
Example 2: Advanced Cancer with Declining Function
Background & Theory
The Karnofsky Performance Scale Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the Karnofsky Performance Scale Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Formula
KPS = Clinician-assessed functional status score (0-100, increments of 10)
The Karnofsky Performance Status scale rates patient functional capacity from 0 (dead) to 100 (normal function, no complaints). Scores are assigned in increments of 10 based on the patient ability to perform normal activities, self-care requirements, and need for institutional or medical assistance.
Worked Examples
Example 1: Post-Surgical Brain Tumor Patient
Problem: A 55-year-old glioblastoma patient, 3 weeks post-craniotomy, can care for himself but cannot return to work as an engineer. He has minor residual left hand weakness. Weight loss is 4% over 2 months. Assess KPS.
Solution: Patient cares for self but unable to do normal work activity = KPS 70\nECOG equivalent = 1\nFunctional category: Unable to work but living at home\nWeight loss 4% = Low nutritional risk\nPrognostic group for GBM with KPS 70+ = More favorable RPA class
Result: KPS 70 | ECOG 1 | Candidate for standard Stupp protocol (radiation + temozolomide). Favorable prognostic category.
Example 2: Advanced Cancer with Declining Function
Problem: A 68-year-old with metastatic pancreatic cancer requires help with bathing and dressing. She spends about 60% of her day in bed. Weight loss is 15% over 3 months. Assess KPS and care recommendations.
Solution: Requires considerable assistance = KPS 40-50\nSpends >50% in bed = KPS 40 (disabled, requires special care)\nECOG equivalent = 3\nWeight loss 15% = Severe malnutrition risk\nPrognostic group = Poor\nHospice consideration threshold met (KPS <= 70)
Result: KPS 40 | ECOG 3 | Poor prognosis. Best supportive care recommended. Hospice referral and palliative care consultation indicated.
Frequently Asked Questions
What is the Karnofsky Performance Status scale?
The Karnofsky Performance Status (KPS) scale is a standardized assessment tool that measures a patient's ability to perform ordinary tasks and activities of daily living. Developed by David Karnofsky and Joseph Burchenal in 1949, it is one of the oldest and most widely used functional assessment tools in oncology. The scale ranges from 0 (dead) to 100 (fully functional with no complaints) in increments of 10. The KPS is divided into three broad functional categories: patients who can carry on normal activity (80-100), patients who are unable to work but can live at home (50-70), and patients who cannot care for themselves (0-40). This tripartite division helps clinicians quickly categorize patients for treatment planning and prognostic discussions.
How does the Karnofsky scale differ from the ECOG scale?
The Karnofsky Performance Status scale uses an 11-point scale (0-100 in increments of 10) while the ECOG scale uses a simpler 6-point scale (0-5). The KPS provides greater granularity, allowing clinicians to detect more subtle changes in functional status over time. For example, a patient deteriorating from KPS 80 to KPS 70 represents a meaningful functional decline that would both fall under ECOG 1. The ECOG scale is more commonly used in modern clinical trial protocols because its simplicity leads to better inter-observer agreement. However, the KPS remains preferred in neuro-oncology, palliative care, and radiation oncology where finer discrimination of functional changes is clinically important. Both scales are validated and can be approximately converted between each other for comparison purposes.
What is the prognostic significance of the Karnofsky score?
The Karnofsky Performance Status is one of the strongest independent predictors of survival across virtually all cancer types. In brain tumors, KPS is a mandatory component of recursive partitioning analysis (RPA) classification and significantly influences treatment decisions. Studies in glioblastoma show that KPS greater than or equal to 70 is associated with median survival approximately twice that of patients with KPS below 70. In lung cancer, each 10-point decrease in KPS is associated with approximately 10-20% increase in mortality risk. For palliative care populations, KPS below 50 is associated with a median survival of approximately 8-12 weeks, while KPS below 30 typically indicates a prognosis of days to weeks. The prognostic value of KPS extends beyond oncology and is used in predicting outcomes in HIV/AIDS, organ transplantation, and geriatric medicine.
What are the limitations of the Karnofsky scale?
The KPS has several well-recognized limitations despite its long history and widespread use. The scale relies on subjective clinician judgment, leading to inter-observer variability particularly at intermediate scores (50-70). The 10-point increments may miss clinically meaningful changes that fall between standard scores. Age-related baseline functional differences are not accounted for, as an 80-year-old and a 40-year-old with identical functional capacities would receive the same score despite very different clinical implications. Cultural and socioeconomic factors influence functional expectations and may bias assessments. The scale was developed in 1949 and does not reflect modern treatment paradigms such as oral targeted therapies or immunotherapies that patients can take at home. Cognitive impairment and psychological symptoms are not adequately captured by the scale. Despite these limitations, KPS remains valuable due to its simplicity, widespread familiarity, and extensive validation data.
Can I use Karnofsky Performance Scale Calculator on a mobile device?
Yes. All calculators on NovaCalculator are fully responsive and work on smartphones, tablets, and desktops. The layout adapts automatically to your screen size.
How do I verify Karnofsky Performance Scale Calculator's result independently?
The Formula section on this page shows the equation used. You can reproduce the calculation manually or in a spreadsheet using those steps. Compare your answer against the worked examples in the Examples section, which use known reference values so you can confirm the calculator is behaving as expected.
References
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy